Bravo to our colleagues in the WHO HIV Department! Pangaea strongly supports WHO's "Treat All" Recommendation that anyone infected with HIV should begin ARV treatment as soon after diagnosis as possible.
Now, the hard work begins making this a reality - and Pangaea will be at the forefront of efforts to promote the development of more effective and affordable treatments for all - including those in middle income countries.
Ben Plumley, CEO Pangaea Global AIDS
Project Inform has published a new informative treatment guide for patients who have been recently been diagnosed with Hepatitis C. As the options for treating hepatitis C (HCV) are increasing, so is the confusion. This is a good problem to have: with more treatment options come more opportunities for people with various HCV genotypes (GT), treatment history and varying levels of cirrhosis to get cured. For more information visit: http://www.projectinform.org/hepc/i-have-hepatitis-c-what-are-my-treatment-options/
Denmark has played an important role in the Global AIDS response. However, at the same time that the Danish government agreed to implement the SDGs, it announced that it has also prepared a finance act that proposes dramatic cuts in the fight against HIV/AIDS.
We understand that this includes a planned yearly cut of 65 million DK to the Global Fund to Fight AIDS, Tuberculosis and Malaria for 2015 and 2016 (almost $20 million USD), despite the promises made by the Danish Prime Minister and Nordic heads of state during US President Obama’s 2013 visit to Stockholm and the pledge made at the Global Fund Replenishment meeting in 2013. The Global Fund is the mechanism through which more than 8 million people have accessed life-saving HIV medicine over the last decade. It provides preventative treatment so that women living with HIV can have HIV-negative babies, and it supports prevention and harm reduction services to underserved populations. Your government is putting these gains at risk and letting people down.
On top of this, the Danish Government proposes to end its contributions to the International HIV/AIDS Alliance, end funding for the International Partnership for Microbicides and International AIDS Vaccine Initiative that advance scientific research in microbicides and AIDS vaccines, as well as decreasing its contributions to UNAIDS, and bilateral support to HIV/AIDS and health programs in high prevalence countries.
These cuts are in sharp contrast to what global leaders committed to in New York in September With ninety other international NGOs, we call on the Danish Government to deliver on the promises it has made to help meet the Sustainable Development Goals, and reverse the threatened cuts to the global AIDS response – and the Global Fund, in particular.
For more information and to read the Open Letter from Civil Society Organizations Around the World please visit the following link
Over 2 years blood, sweat and tears have brought us to this exciting day in Beijing where HIV and breast cancer movements have united to advocate for strengthened screening, treatment and support services in China.
The All China Women Federation launches today The Pink Alliance – a new Chinese public private initiative to scale up community-led breast cancer early detection, support and access to treatment. The Pink Alliance is the result of two years of program development and piloting by V-Med, the implementation agency of AIDS Care China and Pangaea, with funding and technical assistance from Susan G. Komen. Over a decade of expertise from China's HIV community mobilization has been the foundation of our strategy that mobilizes and empowers networks of breast cancer survivors to strengthen early detection and treatment through advocacy, peer support, linkage to health services and workplace-based education.
ACWF Vice President Zhen Yan said "Using ACWF's unrivaled network of national' women's affiliates, the Pink Alliance has already provided for over 6500 women to receive education awareness and information about access to early detection services in Beijing, Shanghai, Xian, Guangzhou and Zhongshan."
Judy Salerno, CEO of Susan G. Komen, added, "Like ACWF, we believe that all women can live healthy and productive lives – free from the threat of breast cancer – when they can have ready access to breast cancer screening, and that the outcomes for women with breast cancer are improved significantly when they can have access to the best treatment, but also access to the support networks of other breast cancer survivors. "
V-Med Women’s Health Director, Tina Lyo said, “ As a woman who has benefited personally from early detection, I passionately believe that all women, regardless of where they live, must have access to regular breast cancer screening and supportive treatment services.
Thomas Cai, V-Med's CEO, Pangaea adviser and founder of ACC added, " Solidarity with HIV shows unquestionably that health services must be rooted in the communities they serve to be most effective and sustainable. Furthermore, both people living with HIV and breast cancer can face terrible stigma and discrimination which have to be faced directly."
AIDS is not one uniform global epidemic, but a series of individual epidemics driven by local circumstances. The need for effective HIV treatment programs that reflect particular contexts has never been greater.
A major new program of Pangaea is, to develop and cost a series of single descriptive case studies documenting effective approaches to HIV service delivery in East and Southern Africa. The goal of this project is to document ARV treatment and support programs that are improving the uptake and retention of clients in care. Pangaea is collaborating with the Clinton Health Access Initiative (CHAI), who will be performing the cost estimates for each of the case studies. The selection of programs for the case study development will seek to present information about a diverse set of programs, looking at both community- and facility-based services and at programs addressing urban and rural populations, key affected populations, and programs that are well integrated with other areas of health services including primary care, sexual, reproductive, and maternal health, and TB services. We are particularly interested in identifying effective HIV treatment initiatives that combine the clinical expertise found in the health facilities and the leadership of the local communities to help as many HIV positive people stay in care and on treatment.
The ultimate goal of the project is to produce clear, policy-relevant cost and effectiveness data around best practices in the HIV space. In addition, dissemination of the methodology used to create the case studies and cost estimates can serve as a template for replication of the process at country levels in order to better understand what program models are working. Through this process, Pangaea seeks to improve uptake and scale of HIV services and fill the gaps in the HIV treatment cascade.
The project is funded by the Bill and Melinda Gates Foundation.
As each case study is finalized, it will be posted on this website. Completed case studies include: